Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis

<div><b>Forest plots of relative risk in PR rate at week 4.</b> CI: confidence interval; M-H: Mantel-Haenszel; RR: relative risk.</div>

BioMed Research International

fig4

Figure 4

Figure 4: Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis 

Figure 4 | Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis 